Showing 21 - 30 of 339,918
This paper analyzes the optimal content regulation of direct-to-consumer advertisement (DTCA) in a pharmaceutical … typical subjective symptoms under enlightenment DTCA. The content regulation changes the nature of market competition and the … of the content regulation is ambiguous and depends, among other things, on the cost effectiveness of advertisement and …
Persistent link: https://www.econbiz.de/10012024745
Die Bundesregierung und die Europäische Kommission mussten in den letzten Wochen viel Kritik bezüglich ihrer Impfstoffbeschaffungsstrategie zur Eindämmung der Corona-Pandemie einstecken. Vor dem Hintergrund zu schleppend erscheinender Impfstofflieferungen und der zunehmenden Gefahr durch die...
Persistent link: https://www.econbiz.de/10012434819
Our calculations indicate that currently proposed U.S. policies to reduce pharmaceutical prices, though particularly beneficial for low-income and elderly populations, could dramatically reduce firms' investment in highly welfare-improving R&D. The U.S. subsidizes the worldwide pharmaceutical...
Persistent link: https://www.econbiz.de/10014576635
oversight of imported food. The FSMA brings the FDA’s food safety regulation in line with core tenets of public health by …
Persistent link: https://www.econbiz.de/10014181189
public expenditure, limiting financial exposure of patients, improving access to pharmaceuticals, and stimulating competition …
Persistent link: https://www.econbiz.de/10014150467
The U.S. Food and Drug Administration (FDA) balances risks and benefits before approving pharmaceuticals, as … any given initial expected risk level, optimal risk-taking decisions involving uncertainty in a multi-period world should …
Persistent link: https://www.econbiz.de/10014148944
particular, is opening up the large Japanese market to pharmaceuticals tested in the West. The FDA Guidance similarly promises to …
Persistent link: https://www.econbiz.de/10014053161
The trade-off between property rights/price regulation and innovation depends on country characteristics and drug …). Regarding price regulation, after a review of theoretical arguments and empirical evidence, seven strategies to reconcile health …
Persistent link: https://www.econbiz.de/10014070742
In this article we analyse the problem of determining the price for new drugs in a market where a stringent budget constraint on public expenditure exists and we suggest an innovative methodology to set their prices. The market is characterised by asymmetry of information and a high proportion...
Persistent link: https://www.econbiz.de/10014071880
In this article we analyse the market for drugs in health care markets where third payers (an insurance company or a government agency) bear the cost and we suggest a common and transparent methodology to set the price for new drugs as well as active principles for which an alternative already...
Persistent link: https://www.econbiz.de/10014028693